| Reference |
|
5287
McKean DJ, Infante AJ, Nilson A, Kimoto M, Fathman CG, Walker E, Warner N.
Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells.
J Exp Med
1981
154(5):1419-31
PubMed ID: 6170720
|
|
980
Metcalf D
Clonal extinction of myelomonocytic leukemic cells by serum from mice injected with endotoxin.
Int J Cancer
1980
25:225-33
PubMed ID: 6967053
|
|
1294
Ralph P, Nakoinz I
Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture.
Cancer Res
1977
37:546-50
PubMed ID: 318922
|
|
716
Ralph P, Nakoinz I
Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
J Immunol
1977
119:950-54
PubMed ID: 894031
|
|
1141
Ralph P, Moore, M A, Nilsson K
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.
J Exp Med
1976
143:1528-33
PubMed ID: 1083890
|
|
5289
Metcalf D, Moore MA, Warner NL.
Colony formation in vitro by myelomonocytic leukemic cells.
J Natl Cancer Inst
1969
43(4):983-1001
PubMed ID: 5259326
|
| User's Publication |
|
11561
Yamada R, Fukumoto R, Noyama C, Fujisawa A, Oka S, Imamura T.
An epidermis-permeable dipeptide is a potential cosmetic ingredient with partial agonist/antagonist activity toward fibroblast growth factor receptors.
J Cosmet Dermatol
2019
19(2):477-484
PubMed ID: 31099492
|
|
11622
Fujino T, Kobayashi Y, Suda K, Koga T, Nishino M, Ohara S, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T.
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro.
J Thorac Oncol
2019
14(10):1753-1765
PubMed ID: 31279006
|
|
11331
Nishino M, Suda K, Kobayashi Y, Ohara S, Fujino T, Koga T, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T.
Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro.
Lung Cancer
2018
PubMed ID: 30527179
|
|
4860
Ishibashi T, Yaguchi A, Terada K, Ueno-Yokohata H, Tomita O, Iijima K, Kobayashi K, Okita H, Fujimura J, Ohki K, Shimizu T, Kiyokawa N.
Ph-like ALL-related novel fusion kinase ATF7IP-PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells.
Exp Hematol
2016
44(3):177-88.e5
PubMed ID: 26703895
|
|
14149
Shimizu K, Yamasaki S, Shinga J, Sato Y, Watanabe T, Ohara O, Kuzushima K, Yagita H, Komuro Y, Asakura M, Fujii S.
Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells
Cancer Res
2016
76(13):3756-66
PubMed ID: 27371739
|
|
15120
Kobayashi Y, Togashi Y, Yatabe Y, Mizuuchi H, Jangchul P, Kondo C, Shimoji M, Sato K, Suda K, Tomizawa K, Takemoto T, Hida T, Nishio K, Mitsudomi T.
EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs
Clin Cancer Res
2015
21(23):5305-13
PubMed ID: 26206867
|
|
8857
Tao Y, Nomura M, Kitabatake N, Tani F.
Mouse CD40-transfected cell lines cannot exhibit the binding and RANTES-stimulating activity of exogenous heat shock protein 70.
Mol. Immunol.
2007
44:1262-73
PubMed ID: 16930707
|
|
2559
Shimizu A, Tada K, Shukunami C, Hiraki Y, Kurokawa T, Magane N, Kurokawa-Seo M
A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells.
J Biol Chem
2001
276:11031-40
PubMed ID: 11134040
|
|
2473
Tanaka I, Ishihara H
Enhanced expression of the early retrotransposon in C3H mouse-derived myeloid leukemia cells.
Virology
2001
280:107-14
PubMed ID: 11162824
|
|
4871
Feng R, Kabayama A, Uchida K, Hoshino H, Miwa M.
Cell-free entry of human T-cell leukemia virus type 1 to mouse cells.
Jpn J Cancer Res
2001
92(4):410-6
PubMed ID: 11346463
|
|
2951
Yokota S, Kayano T, Ohta T, Kurimoto M, Yanagi H, Yura T, Kubota H
Proteasome-dependent degradation of cytosolic chaperonin CCT
Biochemical and biophysical research communications
2000
279:712-717
PubMed ID: 11118350
|
|
2380
Yokota S, Yanagi H, Yura T, Kubota H
Cytosolic chaperonin is up-regulated during cell growth. Preferential expression and binding to tubulin at G(1)/S transition through early S phase.
J Biol Chem
1999
274:37070-8
PubMed ID: 10601265
|
|
2215
Saneyoshi K, Nohara O, Imai T, Shiraishi F, Moriyama H, Fujimaki H
IL-4 and IL-6 production of bone marrow-derived mast cells is enhanced by treatment with environmental pollutants.
Int Arch Allergy Immunol
1997
114:237-45
PubMed ID: 9363904
|
|
2216
Fujimaki H, Nohara O, Katayama N, Abe T, Nohara K
Ganglioside GM3 inhibits interleukin-3-dependent bone marrow-derived mast cell proliferation.
Int Arch Allergy Immunol
1995
107:527-32
PubMed ID: 7620368
|
|
5411
Nakamura M, Sakanaka C, Aoki Y, Ogasawara H, Tsuji T, Kodama H, Matsumoto T, Shimizu T, Noma M.
Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors.
J Biol Chem
1995
270(50):30102-10
PubMed ID: 8530415
|
|
1730
Katayama, N., Honda, Y. and Fujimaki, H.
Growth and Functional Modifications in Formaldehyde-Treated Mouse Bone Marrow-Derived Mast Cells
Toxicol in Vitro
1992
6:239-243
PubMed ID: 20732119
|
|
1731
Fujimaki H, Kawagoe A, Bissonnette E, Befus D
Mast cell response to formaldehyde. 1. Modulation of mediator release.
Int Arch Allergy Immunol
1992
98:324-31
PubMed ID: 1384864
|
Back
Top
CELL BANK Website
